Alliance for Clinical Trials in Oncology

Clinical Trials

Browse or search Alliance’s portfolio of active and completed trials in oncology. Visit ClinicalTrials.gov for contact information, full trial details, eligibility criteria, and how to enroll.

Search by keyword, trial ID, or study chair

Disease/Cancer Type

Alliance Committee

Status

Trial Type

Alliance Committee
Trial Title
Study ID
Disease/Cancer Type
Status
Study Chair Name
Experimental Therapeutics
Sorafenib Tosylate With or Without Everolimus in Treating Patients With Advanced, Radioactive Iodine Refractory Hurthle Cell Thyroid Cancer
NCT02143726
Thyroid & Neuroendocrine / Endocrine Cancers
Open
Eric Sherman, MD
Lymphoma
Epratuzumab and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma
NCT00553501
Lymphoma
Closed
Barbara Grant, MD
Genitourinary Cancer
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
NCT06632977
Prostate Cancer
Open
Rana McKay, MD
Prognostic Study of Metastases in Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Can Be Removed by Surgery
NCT00003901
Lung Cancer & Mesothelioma
Closed
Robbin G. Cohen, MD
Lymphoma
Etoposide in Treating Patients With Relapsed Non-Hodgkin’s Lymphoma
NCT00002880
Lymphoma
Closed
Nancy Bartlett, MD
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
NCT00028574
Prostate Cancer
Closed
Charles Loprinzi, MD
Cancer Control
American Ginseng in Treating Patients With Fatigue Caused by Cancer
NCT00719563
Other Cancer
Closed
Debra Barton, RN, PhD, AOCN, FAAN
Experimental Therapeutics
Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma
NCT02601209
Sarcoma & Soft Tissue / Bone Cancers
Closed
William D Tap
Experimental Therapeutics
Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IV Head and Neck Cancer
NCT01711541
Head & Neck Cancers
Closed
Jonas De Souza
Genitourinary Cancer
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
NCT05987241
Genitourinary Cancers – Kidney / Bladder / Urothelial / Testicular
Open
Matthew D Galsky

Research in Action

See how Alliance trials are advancing treatment

Alliance News